chr21-43063976-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PP3_StrongPP5
The NM_000071.3(CBS):c.752T>C(p.Leu251Pro) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 3)
Consequence
CBS
NM_000071.3 missense
NM_000071.3 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 8.10
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.983
PP5
Variant 21-43063976-A-G is Pathogenic according to our data. Variant chr21-43063976-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 555482.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=3, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBS | NM_000071.3 | c.752T>C | p.Leu251Pro | missense_variant | 9/17 | ENST00000398165.8 | NP_000062.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBS | ENST00000398165.8 | c.752T>C | p.Leu251Pro | missense_variant | 9/17 | 1 | NM_000071.3 | ENSP00000381231.4 |
Frequencies
GnomAD3 genomes Cov.: 3
GnomAD3 genomes
Cov.:
3
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246548Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133446
GnomAD3 exomes
AF:
AC:
1
AN:
246548
Hom.:
AF XY:
AC XY:
1
AN XY:
133446
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome Cov.: 3
GnomAD4 genome
Cov.:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Classic homocystinuria Pathogenic:1Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 08, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 06, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 09, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Feb 22, 2021 | The homozygous c.752T>C (p.Leu251Pro) missense variant identified in the CBS gene has been reported in two affected individuals [PMID:24211323]. One individual [Patient #13] was homozygous for the p.Leu251Pro variant and presented with psychomotor delay and marfanoid features. The second individual [Patient #25] was compound heterozygous for p.Leu251Pro and another missense variant and presented with mild mental retardation, vision problems, and lens ectopia [PMID:24211323]. The p.Leu251Pro has been reported in ClinVar database as a variant of uncertain significance [Variation ID:555482]. The variant is absent from the gnomAD(v3) database suggesting it is not a common benign variant in populations represented in that database. The variant affects a moderately conserved residue and is predicted deleterious by multiple in silico tools [REVEL score= 0.99, CADD score= 32). Functional studies to evaluate the potential consequences of this variant have not been reported. Based on the available evidence, the homozygous c.752T>C (p.Leu251Pro)missense variant identified in the CBS gene is reported as a variant of uncertain significance. - |
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 251 of the CBS protein (p.Leu251Pro). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individuals with homocystinuria due to cystathionine beta-synthase deficiency (PMID: 24211323). ClinVar contains an entry for this variant (Variation ID: 555482). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
CBS-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 19, 2024 | The CBS c.752T>C variant is predicted to result in the amino acid substitution p.Leu251Pro. This variant has been reported in the homozygous or compound heterozygous state in two Turkish individuals with a neurological presentation and elevated homocysteine and methionine in plasma (Karaca et al. 2014. PubMed ID: 24211323). It was also reported in the homozygous state in a patient with classical homocystinuria (Wasim et al. 2022. PubMed ID: 34905667). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. Taken together, this variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;.;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
D;D;D;D
Vest4
MutPred
Loss of stability (P = 0.0052);Loss of stability (P = 0.0052);Loss of stability (P = 0.0052);Loss of stability (P = 0.0052);
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at